Overexpression of Inhibitor of Apoptosis Stimulating Protein of p53 (iASPP), also known as Rel A-associated inhibitor, in tumor cells has been demonstrated to promote cancer growth and drug resistance through high NRF2 levels. The gene discussed is NFE2L2; the disease is cancer.